Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.2 USD
139.73 M USD
675.04 M USD
93.28 M
About Corcept Therapeutics Incorporated
Sector
Industry
CEO
Joseph K. Belanoff
Website
Headquarters
Redwood City
Founded
1998
ISIN
US2183521028
FIGI
BBG00JVRNF23
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0I3Q is 84.0 USD — it has increased by 0.96% in the past 24 hours. Watch Corcept Therapeutics Incorporated. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange Corcept Therapeutics Incorporated. stocks are traded under the ticker 0I3Q.
0I3Q stock has risen by 4.51% compared to the previous week, the month change is a 20.78% rise, over the last year Corcept Therapeutics Incorporated. has showed a 93.17% increase.
We've gathered analysts' opinions on Corcept Therapeutics Incorporated. future price: according to them, 0I3Q price has a max estimate of 145.00 USD and a min estimate of 121.00 USD. Watch 0I3Q chart and read a more detailed Corcept Therapeutics Incorporated. stock forecast: see what analysts think of Corcept Therapeutics Incorporated. and suggest that you do with its stocks.
0I3Q reached its all-time high on Apr 1, 2025 with the price of 115.2 USD, and its all-time low was 11.6 USD and was reached on Feb 25, 2019. View more price dynamics on 0I3Q chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0I3Q stock is 2.08% volatile and has beta coefficient of 0.14. Track Corcept Therapeutics Incorporated. stock price on the chart and check out the list of the most volatile stocks — is Corcept Therapeutics Incorporated. there?
Today Corcept Therapeutics Incorporated. has the market capitalization of 8.84 B, it has increased by 1.14% over the last week.
Yes, you can track Corcept Therapeutics Incorporated. financials in yearly and quarterly reports right on TradingView.
Corcept Therapeutics Incorporated. is going to release the next earnings report on Oct 29, 2025. Keep track of upcoming events with our Earnings Calendar.
0I3Q earnings for the last quarter are 0.29 USD per share, whereas the estimation was 0.19 USD resulting in a 54.67% surprise. The estimated earnings for the next quarter are 0.17 USD per share. See more details about Corcept Therapeutics Incorporated. earnings.
Corcept Therapeutics Incorporated. revenue for the last quarter amounts to 194.43 M USD, despite the estimated figure of 199.39 M USD. In the next quarter, revenue is expected to reach 223.78 M USD.
0I3Q net income for the last quarter is 34.61 M USD, while the quarter before that showed 20.29 M USD of net income which accounts for 70.60% change. Track more Corcept Therapeutics Incorporated. financial stats to get the full picture.
No, 0I3Q doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 27, 2025, the company has 500 employees. See our rating of the largest employees — is Corcept Therapeutics Incorporated. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Corcept Therapeutics Incorporated. EBITDA is 103.84 M USD, and current EBITDA margin is 20.49%. See more stats in Corcept Therapeutics Incorporated. financial statements.
Like other stocks, 0I3Q shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Corcept Therapeutics Incorporated. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Corcept Therapeutics Incorporated. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Corcept Therapeutics Incorporated. stock shows the strong buy signal. See more of Corcept Therapeutics Incorporated. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.